{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:04:28Z","timestamp":1765422268748,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Skin cutaneous melanoma (SKCM) is a highly malignant skin tumor. DIRAS2 is considered to be a tumor suppressor gene; however, its function in SKCM has not been explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Gene Expression Profiling Interactive Analysis (GEPIA) was implemented to investigate the expression of DIRAS2 in SKCM, and plot the survival curve to determine the effect of DIRAS2 on the survival rates of SKCM patients. Then, the correlation between DIRAS2 and tumor immune infiltration was also discussed, and the expression of DIRAS2 and immune infiltration level in SKCM immune cells was determined using TIMER. The top 100 genes most associated with DIRAS2 expression were used for functional enrichment analysis. In order to confirm the anti-cancer effects of DIRAS2 in SKCM in the data analysis, <jats:italic>in vitro<\/jats:italic> assays as well as <jats:italic>in vivo<\/jats:italic> studies of DIRAS2 on SKCM tumor cell proliferation, migration, invasion, and metastasis were conducted. Western blot and immunofluorescence assay were employed to study the relationship between DIRAS2 and Wnt\/\u03b2-catenin signaling pathway in SKCM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DIRAS2 expression was shown to be significantly correlated with tumor grade using univariate logistic regression analysis. DIRAS2 was found to be an independent prognostic factor for SKCM in multivariate analysis. Of note, DIRAS2 expression levels were positively correlated with the infiltration levels of B cells, CD4+ T cells, and CD8+ T cells in SKCM. The infiltration of B cells, CD4+ T cells, and CD8+ T cells was positively correlated with the cumulative survival rate of SKCM patients. <jats:italic>In vitro<\/jats:italic> experiments suggested that proliferation, migration, invasion, and metastasis of SKCM tumor cells were distinctly enhanced after DIRAS2 knockdown. Furthermore, DIRAS2 depletion promoted melanoma growth and metastasis <jats:italic>in vivo<\/jats:italic>. As for the mechanism, silencing DIRAS2 can activate the signal transduction of the Wnt\/\u03b2-catenin signaling pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>DIRAS2 functions as a tumor suppressor gene in cases of SKCM by inhibiting the Wnt\/\u03b2-catenin signaling. It is also associated with immune infiltration in SKCM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.799185","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:32:58Z","timestamp":1652682778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Wenli","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26040785","article-title":"Recent Advances in Nanotechnology for the Treatment of Melanoma","volume":"26","author":"Cassano","year":"2021","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.10.003","article-title":"Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Systematic Review","volume":"34","author":"Hamm","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2018.11.001","article-title":"Clinical Practice Guidelines: Tools to Support High Quality Patient Care","volume":"49","author":"Brouwers","year":"2019","journal-title":"Semin Nucl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02539-9","article-title":"SEOM Clinical Guideline for the Management of Cutaneous Melanoma (2020)","volume":"23","author":"Majem","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/cancers12061613","article-title":"The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal With the AGREE II and AGREE-REX Instruments","volume":"12","author":"Steeb","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00593-9","article-title":"Combining BRAF\/MEK Inhibitors With Immunotherapy in the Treatment of Metastatic Melanoma","volume":"22","author":"Ziogas","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220906011","article-title":"Treatment Exceeds Expectations With Vemurafenib Monotherapy in a Patient With BRAF(V600E)-Mutant Metastatic Melanoma","volume":"26","author":"Yilmaz","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.619003","article-title":"CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000374","article-title":"PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)","volume":"44","author":"Zhang","year":"2021","journal-title":"J Immunother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6648182","article-title":"L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma","volume":"2021","author":"Song","year":"2021","journal-title":"BioMed Res Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27376","article-title":"The Mechanisms of DIRAS Family Members in Role of Tumor Suppressor","volume":"234","author":"Li","year":"2019","journal-title":"J Cell Physiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202150200","article-title":"Di-Ras, a Distinct Subgroup of Ras Family GTPases With Unique Biochemical Properties","volume":"277","author":"Kontani","year":"2002","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1427022","article-title":"RAS-Related GTPases DIRAS1 and DIRAS2 Induce Autophagic Cancer Cell Death and Are Required for Autophagy in Murine Ovarian Cancer Cells","volume":"14","author":"Sutton","year":"2018","journal-title":"Autophagy"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1247-y","article-title":"Di-Ras2 Promotes Renal Cell Carcinoma Formation by Activating the Mitogen-Activated Protein Kinase Pathway in the Absence of Von Hippel-Lindau Protein","volume":"39","author":"Rao","year":"2020","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909","article-title":"The Prognostic Landscape of Genes and Infiltrating Immune Cells Across Human Cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"djw192","DOI":"10.1093\/jnci\/djw192","article-title":"Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer","volume":"109","author":"Bense","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.142193799","article-title":"Rig is a Novel Ras-Related Protein and Potential Neural Tumor Suppressor","volume":"99","author":"Ellis","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.07.019","article-title":"RNAa and Vector-Mediated Overexpression of DIRAS1 Suppresses Tumor Growth and Migration in Renal Cell Carcinoma","volume":"12","author":"Xu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11626-018-0239-5","article-title":"Sodium Butyrate Induces Cell Death by Autophagy and Reactivates a Tumor Suppressor Gene DIRAS1 in Renal Cell Carcinoma Cell Line UOK146","volume":"54","author":"Verma","year":"2018","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2663","article-title":"Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma","volume":"73","author":"Zhu","year":"2013","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.343780","article-title":"The Tumor Suppressor DiRas3 Forms a Complex With H-Ras and C-RAF Proteins and Regulates Localization, Dimerization, and Kinase Activity of C-RAF","volume":"287","author":"Baljuls","year":"2012","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13148-017-0348-0","article-title":"Methylation of DIRAS1 Promotes Colorectal Cancer Progression and may Serve as a Marker for Poor Prognosis","volume":"9","author":"Zheng","year":"2017","journal-title":"Clin Epigenet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.696831","article-title":"The Tumor-Suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions With Oncogenic Small GTPases","volume":"291","author":"Bergom","year":"2016","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31935","article-title":"The Role of Vascular Endothelial Growth Factor, Interleukin 8, and Insulinlike Growth Factor in Sustaining Autophagic DIRAS3-Induced Dormant Ovarian Cancer Xenografts","volume":"125","author":"Mao","year":"2019","journal-title":"Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/onc.2011.213","article-title":"The Tumor-Suppressor Gene ARHI (DIRAS3) Suppresses Ovarian Cancer Cell Migration Through Inhibition of the Stat3 and FAK\/Rho Signaling Pathways","volume":"31","author":"Badgwell","year":"2012","journal-title":"Oncogene"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4161\/cam.23648","article-title":"The Tumor Suppressor Gene ARHI (DIRAS3) Inhibits Ovarian Cancer Cell Migration Through Multiple Mechanisms","volume":"7","author":"Lu","year":"2013","journal-title":"Cell Adh Migr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1867-3","article-title":"Expression of the ADHD Candidate Gene Diras2 in the Brain","volume":"125","author":"Gr\u00fcnewald","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/1087054718822129","article-title":"Knockdown of the ADHD Candidate Gene Diras2 in Murine Hippocampal Primary Cells","volume":"25","author":"Gr\u00fcnewald","year":"2021","journal-title":"J Atten Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.113","article-title":"Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism","volume":"41","author":"Gr\u00fcnewald","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.120","article-title":"DIRAS2 is Associated With Adult ADHD, Related Traits, and Co-Morbid Disorders","volume":"36","author":"Reif","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.06.005","article-title":"Reprogramming Lymphocytes for the Treatment of Melanoma: From Biology to Therapy","volume":"141","author":"Margolis","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703","article-title":"Innate and Adaptive Immune Cells in the Tumor Microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2017.01059","article-title":"The Paradoxical Role of Tumor-Infiltrating Immune Cells in Lung Cancer","volume":"6","author":"Zheng","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00014","article-title":"Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy","volume-title":"Front Immunol","author":"Durgeau","year":"2018"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0685","article-title":"How Do Cytotoxic Lymphocytes Kill Cancer Cells","volume":"21","author":"Mart\u00ednez-Lostao","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the Immune System in Cancer: From Tumor Initiation to Metastatic Progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0431","article-title":"The Emerging Role of B Cells in Tumor Immunity","volume":"76","author":"Tsou","year":"2016","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/cells8050449","article-title":"The B-Side of Cancer Immunity: The Underrated Tune","volume":"8","author":"Largeot","year":"2019","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2015.01.002","article-title":"Tumor-Associated Macrophages as an Emerging Target Against Tumors: Creating a New Path From Bench to Bedside","volume":"1855","author":"Jinushi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.12.010","article-title":"Therapeutic Targeting of the Oncogenic Wnt Signaling Pathway for Treating Colorectal Cancer and Other Colonic Disorders","volume":"169","author":"Caspi","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-Catenin Signaling Pathway in Cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt Signaling in Breast Cancer: Biological Mechanisms, Challenges and Opportunities","volume":"19","author":"Xu","year":"2020","journal-title":"Mol Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.10.047","article-title":"Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer","volume":"160","author":"Togasaki","year":"2021","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1038\/s41467-020-19627-7","article-title":"IRF3 Prevents Colorectal Tumorigenesis via Inhibiting the Nuclear Translocation of \u03b2-Catenin","volume":"11","author":"Tian","year":"2020","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-020-18643-x","article-title":"Fgf and Wnt Signaling Interaction in the Mesenchymal Niche Regulates the Murine Hair Cycle Clock","volume":"11","author":"Harshuk-Shabso","year":"2020","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0129-0","article-title":"C-Myc Inhibits Myoblast Differentiation and Promotes Myoblast Proliferation and Muscle Fibre Hypertrophy by Regulating the Expression of its Target Genes, miRNAs and lincRNAs","volume":"26","author":"Luo","year":"2019","journal-title":"Cell Death Differ"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30801","article-title":"Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance C-Myc Gene Expression and Protein Stability","volume":"71","author":"Wu","year":"2020","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30172","article-title":"Heat Shock Protein 90\u03b1-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene C-MYC mRNA Stability","volume":"69","author":"Zhou","year":"2019","journal-title":"Hepatology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.799185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:33:02Z","timestamp":1652682782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.799185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":49,"alternative-id":["10.3389\/fonc.2022.799185"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.799185","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"799185"}}